UVALDE MEMORIAL HOSPITAL — History
CCN 451387 | 3-year financial timeline | COVID resilience: 67/100
🛡️ Public data only — no PHI permitted on this instance.
$90M
Latest Revenue (FY2022)
+14.0%
Revenue CAGR (3yr)
30.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $69M | $82M | $90M | +9.8% | +14.0% |
| Operating Expenses | $49M | $56M | $63M | +12.9% | +13.7% |
| Operating Margin | 29.7% | 32.1% | 30.1% | -6.1% | +0.6% |
| Net Income | $21M | $26M | $27M | +3.1% | +14.7% |
| Licensed Beds | 21 | 21 | 21 | +0.0% | +0.0% |
| Total Patient Days | 6,470 | 6,847 | 5,118 | -25.3% | -11.1% |
| Medicare Day % | 25% | 23% | 23% | -1.6% | -3.9% |
| Medicaid Day % | 1% | 1% | 1% | -8.1% | +2.8% |
COVID Impact & Recovery
Resilience Score: 67/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +30.0% ($69M → $90M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▶ Stable
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+14.0%
This Hospital
+7.6%
State Avg
Latest Margin
30.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $100M | 30.3% |
| FY2024 (proj) | $111M | 30.5% |
| FY2025 (proj) | $121M | 30.7% |